2,3-Bis(bromomethyl)quinoxaline-6-carboxylic acid

Catalog No. :
ACICSJ834
CAS No. :
32602-11-2
Molecular Formula :
C11H8Br2N2O2
Molecular Weight :
360.01

IUPAC Name:2,3-bis(bromomethyl)quinoxaline-6-carboxylic acid

2,3-Bis(bromomethyl)quinoxaline-6-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$73.00Login to see priceIn stockInquiry
50mg98%$123.00Login to see priceIn stockInquiry
100mg98%$207.00Login to see priceIn stockInquiry
250mg98%$352.00Login to see priceIn stockInquiry
1g98%$1125.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Bis(bromomethyl)quinoxaline-6-carboxylic acid
IUPAC Name2,3-bis(bromomethyl)quinoxaline-6-carboxylic acid
MDL No.MFCD29472291
Molecular FormulaC11H8Br2N2O2
Molecular Weight360.01
SMILESO=C(C1=CC=C2N=C(CBr)C(CBr)=NC2=C1)O
InChI KeyQGKACHNDUYVGLW-UHFFFAOYSA-N
Synonym6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)-;2,3-bis(bromomethyl)quinoxaline-6-carboxylic acid
CAS No.32602-11-2

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACICSJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACICSJ834 route product structure diagram
    ACICSJ83432602-11-2 In Stock
Inquiry

2. ACICSJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACICSJ834 route product structure diagram
    ACICSJ83432602-11-2 In Stock
Inquiry

Comments (0)